Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Tortora · SciRah

Researcher profile · Semantic Scholar

G. Tortora

Share profile

G. Tortora — researcher profile on SciRah

h-index: 78
Works: 755
Citations: 39K

Most-cited papers

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
C. Antoniotti, D. Rossini, F. Pietrantonio, A. Catteau +33 more
2022The Lancet Oncology207 citations Open access
Semantic Scholar
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
M. Tempero, U. Pelzer, E. O'Reilly, J. Winter +27 more
2022Journal of Clinical Oncology116 citations Open access
Semantic Scholar
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
J. van de Haar, Xu-Hui Ma, S. Ooft, Pim W. van der Helm +46 more
2023Nature Medicine80 citations Open access
Semantic Scholar
Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): First results of the CheckMate 8HW study.
Thierry Andre, E. Élez, E. Van Cutsem, Lars Henrik Jensen +16 more
2024Journal of Clinical Oncology55 citations
Semantic Scholar
Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers
M. Chiaravalli, A. Spring, Antonio Agostini, G. Piro +2 more
2022Cells46 citations Open access
Semantic Scholar
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis.
P. Lombardi, M. Filetti, R. Falcone, R. di Bidino +6 more
2022Cancer Treatment Reviews42 citations
Semantic Scholar
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making
F. Pavese, E. Capoluongo, M. Muratore, A. Minucci +21 more
2022Cancers40 citations Open access
Semantic Scholar
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario.
C. Ciccarese, A. Strusi, D. Arduini, P. Russo +5 more
2023Cancer Treatment Reviews37 citations Open access
Semantic Scholar
Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches
C. Cencioni, I. Trestini, G. Piro, E. Bria +3 more
2022Nutrients34 citations Open access
Semantic Scholar
REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives
U. Boggi, E. Kauffmann, N. Napoli, S. Barreto +146 more
2024Updates in Surgery33 citations Open access
Semantic Scholar
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives.
M. Bauckneht, C. Ciccarese, Riccardo Laudicella, C. Mosillo +8 more
2024Cancer Treatment Reviews33 citations Open access
Semantic Scholar
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer
Veronica Ruta, C. Naro, M. Pieraccioli, Adriana Leccese +17 more
2024Cell Reports Medicine32 citations Open access
Semantic Scholar
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience.
Federica Borrelli de Andreis, I. Boškoski, P. Mascagni, T. Schepis +10 more
2023Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]28 citations Open access
Semantic Scholar
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer
G. Piro, C. Carbone, Antonio Agostini, A. Esposito +13 more
2022British Journal of Cancer28 citations Open access
Semantic Scholar
Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives
S. Pannunzio, A. Di Bello, D. Occhipinti, A. Scala +6 more
2024Frontiers in Oncology27 citations Open access
Semantic Scholar
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents
G. Garufi, L. Carbognin, F. Schettini, E. Seguí +6 more
2022Cancers26 citations Open access
Semantic Scholar
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies
M. Cintoni, F. Grassi, M. Palombaro, E. Rinninella +8 more
2023Nutrients25 citations Open access
Semantic Scholar
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study
F. Lococo, L. Boldrini, Charles-Davies Diepriye, Jessica Evangelista +29 more
2023BMC Cancer24 citations Open access
Semantic Scholar
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
E. Gurreri, G. Genovese, L. Perelli, Antonio Agostini +3 more
2023International Journal of Molecular Sciences24 citations Open access
Semantic Scholar
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations.
R. Iacovelli, C. Ciccarese, G. Procopio, S. Astore +6 more
2022Cancer Treatment Reviews24 citations Open access
Semantic Scholar
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
A. Botticelli, G. Pomati, A. Cirillo, S. Scagnoli +16 more
2022Frontiers in Immunology21 citations Open access
Semantic Scholar
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center
C. Nero, S. Duranti, Flavia Giacomini, A. Minucci +11 more
2022Journal of Personalized Medicine20 citations Open access
Semantic Scholar
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms
A. Agostini, G. Piro, F. Inzani, G. Quero +14 more
2024Nature Communications19 citations Open access
Semantic Scholar
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
A. Fabi, L. Carbognin, A. Botticelli, I. Paris +20 more
2023npj Breast Cancer19 citations Open access
Semantic Scholar
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?
G. Garufi, L. Carbognin, C. Arcanà, S. Parola +13 more
2022Cancer Treatment Reviews19 citations
Semantic Scholar
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response
M. Pasqualoni, A. Orlandi, A. Palazzo, G. Garufi +8 more
2023Frontiers in Oncology17 citations Open access
Semantic Scholar
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
C. Ciccarese, R. Iacovelli, S. Buti, F. Primi +12 more
2022Anticancer Research16 citations
Semantic Scholar
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study
U. Basso, F. Paolieri, M. Rizzo, U. de Giorgi +17 more
2022Cancers15 citations Open access
Semantic Scholar
A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants
Luciano Giacò, F. Palluzzi, Davide Guido, C. Nero +12 more
2022Cancers14 citations Open access
Semantic Scholar
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study
E. Rossi, L. Boldrini, M. Maratta, R. Gatta +3 more
2023Human Vaccines & Immunotherapeutics13 citations Open access
Semantic Scholar
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer
A. Agostini, Ilaria Guerriero, G. Piro, G. Quero +20 more
2023Journal of Translational Medicine13 citations Open access
Semantic Scholar
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis
L. Mastrantoni, A. Orlandi, A. Palazzo, G. Garufi +5 more
2023EClinicalMedicine12 citations Open access
Semantic Scholar
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)
E. Vita, A. Stefani, G. Piro, L. Mastrantoni +19 more
2023Cancer Immunology and Immunotherapy12 citations Open access
Semantic Scholar
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers.
R. Iacovelli, D. Arduini, C. Ciccarese, F. Pierconti +6 more
2022Critical reviews in oncology/hematology12 citations
Semantic Scholar
Fecal microbiota transplantation to improve efficacy of immune checkpoint inhibitors in renal cell carcinoma (TACITO trial).
Serena Porcari, C. Ciccarese, Federica Pinto, G. Quaranta +16 more
2022Journal of Clinical Oncology12 citations
Semantic Scholar
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
A. Stefani, G. Piro, F. Schietroma, A. Strusi +12 more
2022Frontiers in Oncology12 citations Open access
Semantic Scholar
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study.
R. Iacovelli, C. Ciccarese, S. Buti, P. Zucali +21 more
2024European Urology11 citations Open access
Semantic Scholar
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials
L. Mastrantoni, G. Garufi, E. Di Monte, N. Maliziola +10 more
2023Therapeutic Advances in Medical Oncology11 citations Open access
Semantic Scholar
Safety and Feasibility of Analgosedation for Electrochemotherapy of Liver Lesions
R. Iezzi, A. Posa, C. Caputo, Davide De Leoni +6 more
2023Life11 citations Open access
Semantic Scholar
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study
E. Rossi, I. Zizzari, A. Di Filippo, A. Acampora +11 more
2022Human Vaccines & Immunotherapeutics11 citations Open access
Semantic Scholar
Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives
R. Iacovelli, C. M. Cicala, C. Ciccarese, E. Sacco +3 more
2022Urologiâ10 citations
Semantic Scholar
Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients
F. Miglietta, L. Pontolillo, C. de Angelis, R. Caputo +15 more
2024Breast9 citations Open access
Semantic Scholar
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study
Filippo Lococo, L. Boldrini, Charles-Davies Diepriye, Jessica Evangelista +29 more
2023BMC Cancer9 citations Open access
Semantic Scholar
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients
E. Rossi, F. Cellini, M. Pagliara, M. G. Sammarco +8 more
2023Cancers8 citations Open access
Semantic Scholar
Maintenance Strategies After Anti-EGFR-based Induction in Metastatic Colorectal Cancer: A Systematic Review and Bayesian Network Meta-analysis.
L. Mastrantoni, V. Beccia, G. Caira, G. Trovato +7 more
2023Critical reviews in oncology/hematology8 citations Open access
Semantic Scholar
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics
M. Chiappetta, D. Tabacco, A. Iaffaldano, Jessica Evangelista +15 more
2022Life8 citations Open access
Semantic Scholar
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)
G. Orsi, A. Cavaliere, G. Tortora, S. Lonardi +29 more
2022British Journal of Cancer8 citations Open access
Semantic Scholar
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies
A. Rachiglio, L. Forgione, R. Pasquale, C. Barone +20 more
2022Cancers8 citations Open access
Semantic Scholar
Post-traumatic growth in oncological patients during the COVID-19 pandemic
L. Lafuenti, L. Dinapoli, L. Mastrilli, Vezio Savoia +6 more
2023Health Psychology Report7 citations Open access
Semantic Scholar
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
G. Garufi, L. Carbognin, I. Sperduti, F. Miglietta +18 more
2023Therapeutic Advances in Medical Oncology7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Bria×18
Invite
E. Bria — researcher profile on SciRah
C. Carbone×10
Invite
C. Carbone — researcher profile on SciRah
G. Piro×9
Invite
G. Piro — researcher profile on SciRah
R. Iacovelli×9
Invite
R. Iacovelli — researcher profile on SciRah

×9

Invite

C. Ciccarese — researcher profile on SciRah

Invite

A. Fabi — researcher profile on SciRah

Invite

A. Orlandi — researcher profile on SciRah

Invite

G. Scambia — researcher profile on SciRah

G. Schinzari×6

Invite

G. Schinzari — researcher profile on SciRah

Invite

G. Garufi — researcher profile on SciRah

Invite

A. Minucci — researcher profile on SciRah

L. Carbognin×5

Invite

L. Carbognin — researcher profile on SciRah